The FFR-IQ software recently demonstrated a 92.2 percent sensitivity for non-invasive estimation of fractional flow reserve (FFRC) based on coronary CT angiography (CCTA) scans.
|Articles|June 21, 2005
Report from SNM: PET/CT produces Image of the Year
The ability to simultaneously display 3D anatomic and molecular information to evaluate lung cancer earned Dr. Andrew Quon recognition for the Society of Nuclear Medicine’s Image of the Year.
Advertisement
The ability to simultaneously display 3D anatomic and molecular information to evaluate lung cancer earned Dr. Andrew Quon recognition for the Society of Nuclear Medicine's Image of the Year. Dr. Henry Wagner singled out an example of 3D FDG-PET/CT bronchoscopy produced by Quon, an assistant professor of radiology at the Institute for Molecular Imaging at Stanford University. The image employs metabolic FDG-PET to identify the position of a primary cancer lesion in a lung and an avid mediastinal lymph node partially obscured by the bronchus. Three-D-rendered multislice CT contributes a stunning view of surrounding anatomy. It allows the physician to rule out endobronchial involvement. Wagner, a professor of environmental health sciences at Johns Hopkins University, announced the selection Monday at the SNM meeting in Toronto.
Advertisement
Related to this article
Catch up on the top radiology content of the past week.
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
2
Can MRI-Based AI Have an Impact in Reducing Unnecessary Prostate Biopsies?
3
The Reading Room Podcast: A Closer Look at New Research on 177Lu-Edotreotide for Treating GEP-NETs
4
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
5